This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: general practice

October 2021 Br J Cardiol 2021;28:153–4 doi:10.5837/bjc.2021.044

Analysis of the trend in community prescribing of RAAS inhibitors during the COVID-19 pandemic

Layla Guscoth, Sam Hodgson

Abstract

Introduction From December 2019, SARS-CoV-2, a novel coronavirus, sparked a global pandemic and rapid scientific responses to the new coronavirus 2019 (COVID-19) disease. Rapid identification showed the angiotensin-converting enzyme 2 (ACE-2) as the host receptor for SARS-CoV-2. Given this, concerns were raised that renin–angiotensin–aldosterone system (RAAS) inhibitors, such as ACE inhibitors and angiotensin-receptor blockers (ARBs), which may increase the expression of ACE‑2, could negatively influence COVID-19 outcomes. This led to significant media attention and anxiety about ongoing use of these medications. However, there has bee

| Full text
The post-ACS patient: shared care to improve outcomes

September 2017 Br J Cardiol 2017;24(suppl 1):S16–S20 doi:10.5837/bjc.2017.s03

The post-ACS patient: shared care to improve outcomes

Terry McCormack, Joe Mills

Abstract

Introduction In 1988 the ISIS-2 (Second International Study of Infarct Survival) study brought about a sea change in the management of the patient suffering a myocardial infarction (MI) and, in particular, those who had ST-elevation (STEMI) changes on their electrocardiogram (ECG).1 Prior to that landmark trial, general practitioners (GPs) were much more involved in the care of patients suffering MIs. They had to decide with what urgency the patient had to be admitted, or even if they would be admitted at all, in the light of how little could be done for the patient in hospital. The care provided has improved since then to the point that the

| Full text

June 2017 Br J Cardiol 2017;24:47-8 doi:http://doi.org/10.5837/bjc.2017.014

A triumph of British cardiovascular medicine: “… and the last can be first…”

Adrian J B Brady

Abstract

The Gospel of Matthew tells us, “…the last can be first…” Nowhere is this truer than the towering UK success of that fundamental cornerstone of cardiovascular prevention, cholesterol-lowering therapy. In 2002, BJC published a paper showing how far the UK lagged behind other countries in Europe when it came to prescribing lipid-lowering drugs.1 At the same time, a number of other very large UK surveys were published.2 All showed that the UK was the sick man of Europe, with limited statin prescribing in the face of a huge burden of cardiovascular disease. Figure 1. Coronary heart disease (CHD) mortality compared to statin sales: Aug

| Full text
The effectiveness of a mobile ECG device in identifying AF: sensitivity, specificity and predictive value

April 2015 Br J Cardiol 2015;22:70–2 doi:10.5837/bjc.2015.013 Online First

The effectiveness of a mobile ECG device in identifying AF: sensitivity, specificity and predictive value

Jonathan Williams, Keith Pearce, Ivan Benett

Abstract

Introduction People with atrial fibrillation (AF) are five times more likely to have a stroke.1 AF is an increasing problem as our population gets older.2 It is, therefore, important to be able to identify this condition as early as possible, when intervention with anticoagulation can prevent stroke, as is recommended by the National Institute for Health and Care Excellence (NICE), in most cases.3 Several studies have attempted to identify the most effective way of screening for, or case-finding, AF.4-7 The gold standard for diagnosis of AF is a 12-lead electrocardiogram (ECG). However, the 12-lead ECG is an impractical diagnostic tool for a

| Full text
Echocardiography is not indicated for an enlarged cardiothoracic ratio

November 2013 Br J Cardiol 2013;20:149–150 doi:10.5837/bjc.2013.30

Echocardiography is not indicated for an enlarged cardiothoracic ratio

Lucinda Wingate-Saul, Yassir Javaid, John Chambers

Abstract

(more…)

| Full text

May 2008 Br J Cardiol 2008;15:141–4

Availability of cardiac equipment in general practice premises in a cardiac network: a survey

Alison Day, Carol Oldroyd, Sonia Godfrey, Tom Quinn

Abstract

Background Cardiovascular diseases are the most common cause of premature death in developed countries. The National Service Framework for Coronary Heart Disease (NSF CHD)1 sets out national standards for the prevention, diagnosis and treatment of CHD including explicit recognition of the role of primary care teams. A further NSF chapter ‘Arrhythmias and sudden cardiac death’ was published in 2005,2 emphasising that patients with long-term conditions may be managed in primary care. It also highlighted better access to effective management of arrhythmias in all areas, including primary care. Cardiovascular diagnostic and monitoring equipm

| Full text

November 2006 Br J Cardiol 2006;13:367-9

The impact of the new GP contract on measurement of lipids and use of statins in the over 80s with coronary heart disease

Samira Siddiqui, Chris Isles, Ewan Bell, Alan Begg

Abstract

No content available

| Full text

July 2006 Br J Cardiol 2006;13:297-300

How well informed are general practitioners about management strategies to improve the prognosis of heart failure?

Archana Rao, John Walsh, David Gray

Abstract

No content available

| Full text

November 2005 Br J Cardiol 2005;12:471-6

Hypertension – its detection, prevalence, control and treatment in a quality driven British general practice

Peter Standing, Helen Deakin, Paul Norman, Ruth Standing

Abstract

No content available

| Full text

November 2004 Br J Cardiol 2004;11:495-6

Education – the dawning of a new era?

Sally Smith

Abstract

No content available

| Full text

For healthcare professionals only

Add Banner

Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now